Hydrocephalus Shunts Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$2500
Buy Report View Sample

Published: April 22, 2022 Report Code: GDME1334EPD-ST

Select Item

Hydrocephalus Shunts Pipeline Products Market Overview

Shunts allow excess cerebrospinal fluid (CSF) to drain to another area of the body. The Hydrocephalus Shunts pipeline market research report provides comprehensive information about the Hydrocephalus Shunts pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Hydrocephalus Shunts Pipeline Products Market by Segments

The key segment in the Hydrocephalus Shunts pipeline products market is Hydrocephalus Catheters.

Hydrocephalus Shunts Pipeline Products Market Segmentation by Territories

The key territories with products in the pipeline are the US, Europe, Argentina, Israel, and Japan, among others. As of April 2022, the US has the highest number of products in the pipeline out of them all.

Hydrocephalus Shunts Pipeline Products Market Analysis, by Territories

Hydrocephalus Shunts Pipeline Products Market Analysis, by TerritoriesFor more territory insights into the Hydrocephalus Shunts pipeline products market, download a free report sample

Hydrocephalus Shunts Pipeline Products Market Segmentation by Regulatory Paths

The key regulatory paths followed by the Hydrocephalus Shunts pipeline products market are 510(k), CE, and Ninsho. Most of the products follow the 510(k) pathway to enter the market.

Hydrocephalus Shunts Pipeline Products Market Analysis, by Regulatory Paths

Hydrocephalus Shunts Pipeline Products Market Analysis, by Regulatory PathsFor more Hydrocephalus Shunts pipeline products regulatory path insights, download a free report sample

Hydrocephalus Shunts Pipeline Products Market - Competitive Landscape

Some of the leading companies in the Hydrocephalus Shunts pipeline products market are Anuncia Inc, Arkis BioSciences, Beckersmith Medical, Inc., Biosan Medical Ltd, CereVasc LLC, CSF-Dynamics AS, FreeFlow Medical Devices LLC, Georgia Institute of Technology, H-Cubed Inc., and Integra LifeSciences Holdings Corp.

Biosan Medical Ltd.: It is a medical device company that develops patented surgical devices. It also provides methods for the treatment of stroke and intraventricular hemorrhages of different etiologies. Biosan Medical is headquartered in Rishon Le’Zion, Israel.

Georgia Institute of Technology: It operates as a research university that offers undergraduate, graduate and research programs. The university provides various bachelor’s degrees, master’s degrees, and doctoral degree programs. Georgia Tech also offers research services in the areas of software engineering, artificial intelligence and machine learning, cybersecurity, and risk management among others. The university offers outstanding programs in business, design, liberal arts, and sciences. It operates in China, France, and China. Georgia Tech is headquartered in Atlanta, Georgia, the US.

Integra LifeSciences Holdings Corp: It is a medical technology company that offers engineered collagen-based product lines. Integra’s products find application in orthopedic extremity surgery, neurosurgery, and reconstructive and general surgery. Integra serves hospitals, outpatient surgery centers, physicians, veterinarian, and dental practices. The company markets its solutions through direct sales representatives and an extensive network of distributors. Integra is headquartered in Plainsboro, New Jersey, the US.

Hydrocephalus Shunts Pipeline Products Market Report Overview

Key Segments Hydrocephalus Catheters
Key Territories The US, Europe, Argentina, Israel, and Japan
Key Regulatory Paths 510(k), CE, and Ninsho
Leading Companies Anuncia Inc, Arkis BioSciences, Beckersmith Medical, Inc., Biosan Medical Ltd, CereVasc LLC, CSF-Dynamics AS, FreeFlow Medical Devices LLC, Georgia Institute of Technology, H-Cubed Inc., and Integra LifeSciences Holdings Corp

Scope

This report provides:

  • Extensive coverage of the Hydrocephalus Shunts under development.
  • Reviews of details of major pipeline products which includes product description, licensing and collaboration details, and other developmental activities.
  • Reviews of the major players involved in the development of Hydrocephalus Shunts and lists all their pipeline projects.
  • The coverage of pipeline products based on various stages of development ranging from early development to the approved/issued stage.
  • Key clinical trial data of ongoing trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.

  • Identify emerging players with a potentially strong product portfolio and create effective counter strategies to gain a competitive advantage.

  • Identify and understand important and diverse types of Hydrocephalus Shunts under development.

  • Develop market-entry and market-expansion strategies.

  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.

  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date.

Anuncia Inc
Arkis BioSciences
Beckersmith Medical, Inc.
Biosan Medical Ltd
CereVasc LLC
CSF-Dynamics AS
FreeFlow Medical Devices LLC
Georgia Institute of Technology
H-Cubed Inc.
Integra LifeSciences Holdings Corp
Johns Hopkins University
Microbot Medical Ltd
Monitor Med Solutions
NeuraMedica, LLC
Sree Chitra Tirunal Institute for Medical Sciences & Technology
System Science Inc.
University Hospital Zurich
University of California Los Angeles
University of Iowa
University of Rochester
University of South Florida
University of Wisconsin Madison
Vivonics Inc
Wayne State University

Table of Contents

1 Table of Contents

2 Introduction 8

2.1 Hydrocephalus shunts Overview 8

3 Products under Development 9

3.1 Hydrocephalus shunts – Pipeline Products by Stage of Development 9

3.2 Hydrocephalus shunts – Pipeline Products by Segment 10

3.3 Hydrocephalus shunts – Pipeline Products by Territory 11

3.4 Hydrocephalus shunts – Pipeline Products by Regulatory Path 12

3.5 Hydrocephalus shunts – Pipeline Products by Estimated Approval Date 13

3.6 Hydrocephalus shunts – Ongoing Clinical Trials 14

4 Hydrocephalus shunts – Pipeline Products under Development by Companies 15

4.1 Hydrocephalus shunts Companies – Pipeline Products by Stage of Development 15

4.2 Hydrocephalus shunts – Pipeline Products by Stage of Development 16

5 Hydrocephalus shunts Companies and Product Overview 17

5.1 Anuncia Inc Company Overview 17

5.1.1 Anuncia Inc Pipeline Products & Ongoing Clinical Trials Overview 17

5.2 Arkis BioSciences Company Overview 18

5.2.1 Arkis BioSciences Pipeline Products & Ongoing Clinical Trials Overview 18

5.3 Beckersmith Medical, Inc. Company Overview 19

5.3.1 Beckersmith Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 19

5.4 Biosan Medical Ltd Company Overview 20

5.4.1 Biosan Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 20

5.5 CereVasc LLC Company Overview 21

5.5.1 CereVasc LLC Pipeline Products & Ongoing Clinical Trials Overview 21

5.6 CSF-Dynamics AS Company Overview 24

5.6.1 CSF-Dynamics AS Pipeline Products & Ongoing Clinical Trials Overview 24

5.7 FreeFlow Medical Devices LLC Company Overview 25

5.7.1 FreeFlow Medical Devices LLC Pipeline Products & Ongoing Clinical Trials Overview 25

5.8 Georgia Institute of Technology Company Overview 26

5.8.1 Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 26

5.9 H-Cubed Inc. Company Overview 27

5.9.1 H-Cubed Inc. Pipeline Products & Ongoing Clinical Trials Overview 27

5.10 Integra LifeSciences Holdings Corp Company Overview 28

5.10.1 Integra LifeSciences Holdings Corp Pipeline Products & Ongoing Clinical Trials Overview 28

5.11 Johns Hopkins University Company Overview 30

5.11.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 30

5.12 Microbot Medical Ltd Company Overview 31

5.12.1 Microbot Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 31

5.13 Monitor Med Solutions Company Overview 34

5.13.1 Monitor Med Solutions Pipeline Products & Ongoing Clinical Trials Overview 34

5.14 NeuraMedica, LLC Company Overview 35

5.14.1 NeuraMedica, LLC Pipeline Products & Ongoing Clinical Trials Overview 35

5.15 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview 36

5.15.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 36

5.16 System Science Inc. Company Overview 37

5.16.1 System Science Inc. Pipeline Products & Ongoing Clinical Trials Overview 37

5.17 University Hospital Zurich Company Overview 39

5.17.1 University Hospital Zurich Pipeline Products & Ongoing Clinical Trials Overview 39

5.18 University of California Los Angeles Company Overview 40

5.18.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 40

5.19 University of Iowa Company Overview 41

5.19.1 University of Iowa Pipeline Products & Ongoing Clinical Trials Overview 41

5.20 University of Rochester Company Overview 42

5.20.1 University of Rochester Pipeline Products & Ongoing Clinical Trials Overview 42

5.21 University of South Florida Company Overview 43

5.21.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 43

5.22 University of Wisconsin Madison Company Overview 45

5.22.1 University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview 45

5.23 Vivonics Inc Company Overview 48

5.23.1 Vivonics Inc Pipeline Products & Ongoing Clinical Trials Overview 48

5.24 Wayne State University Company Overview 49

5.24.1 Wayne State University Pipeline Products & Ongoing Clinical Trials Overview 49

6 Hydrocephalus shunts- Recent Developments 50

6.1 Feb 24, 2022: LeMaitre Q4 2021 Financial Results 50

6.2 Feb 11, 2022: LeMaitre Will Announce Fourth Quarter 2021 Earnings Results February 24, 2022 51

6.3 Jan 11, 2022: Integra LifeSciences Reports Preliminary Fourth Quarter and Full-Year 2021 Revenue and Plans $125 Million Share Repurchase 51

6.4 Jan 04, 2022: Medtronic Chairman and CEO Geoff Martha to speak at J.P. Morgan healthcare conference 52

6.5 Dec 08, 2021: Dr Jens von Lackum appointed to the Management Board of B. Braun SE 53

6.6 Oct 28, 2021: LeMaitre Q3 2021 Financial Results 53

6.7 Oct 14, 2021: LeMaitre Will Announce Third Quarter 2021 Earnings Results on October 28, 2021 54

6.8 Sep 02, 2021: Integra LifeSciences Announces Participation In Upcoming Investor Conferences 54

6.9 Jul 29, 2021: LeMaitre Q2 2021 Financial Results 54

6.10 Jul 28, 2021: Integra LifeSciences Reports Second Quarter 2021 Financial Results 55

6.11 Jul 15, 2021: LeMaitre Will Announce Second Quarter 2021 Earnings Results on July 29, 2021 58

6.12 Jul 13, 2021: LeMaitre Provides Q2 2021 Update 58

6.13 Jun 30, 2021: B. Braun Announces Jennifer Prioleau as New Chief Legal Officer and Chief Compliance Officer 59

6.14 May 20, 2021: Integra LifeSciences Hosts Virtual Investor Day 59

6.15 May 07, 2021: Integra LifeSciences To Host Virtual Investor Day On May 20, 2021 61

6.16 Apr 29, 2021: LeMaitre Q1 2021 Financial Results 61

7 Appendix 63

7.1 Methodology 63

7.2 About GlobalData 66

7.3 Contact Us 66

7.4 Disclaimer 66

Table

Hydrocephalus shunts – Pipeline Products by Stage of Development 9

Hydrocephalus shunts – Pipeline Products by Segment 10

Hydrocephalus shunts – Pipeline Products by Territory 11

Hydrocephalus shunts – Pipeline Products by Regulatory Path 12

Hydrocephalus shunts – Pipeline Products by Estimated Approval Date 13

Hydrocephalus shunts – Ongoing Clinical Trials 14

Hydrocephalus shunts Companies – Pipeline Products by Stage of Development 15

Hydrocephalus shunts – Pipeline Products by Stage of Development 16

Anuncia Inc Pipeline Products & Ongoing Clinical Trials Overview 17

ReFlow System Mini – Product Status 17

ReFlow System Mini – Product Description 17

Arkis BioSciences Pipeline Products & Ongoing Clinical Trials Overview 18

Arkis AutoShunt – Product Status 18

Arkis AutoShunt – Product Description 18

Beckersmith Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 19

FlowSafe – Product Status 19

FlowSafe – Product Description 19

Biosan Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 20

Ventritek105 – Product Status 20

Ventritek105 – Product Description 20

CereVasc LLC Pipeline Products & Ongoing Clinical Trials Overview 21

eShunt – Product Status 21

eShunt – Product Description 21

CereVasc LLC – Ongoing Clinical Trials Overview 22

eShunt – Pilot Study to Evaluate the Safety and Effectiveness of the CereVasc eShunt System in the Treatment of Communicating Hydrocephalus 23

eShunt – Pilot Study to Evaluate the Safety and Effectiveness of the CereVasc eShunt System in the Treatment of Normal Pressure Hydrocephalus 23

eShunt – US Pilot Study to Evaluate the Safety and Effectiveness of the CereVasc eShunt System in the Treatment of Normal Pressure Hydrocephalus 23

CSF-Dynamics AS Pipeline Products & Ongoing Clinical Trials Overview 24

SinuShunt – Product Status 24

SinuShunt – Product Description 24

FreeFlow Medical Devices LLC Pipeline Products & Ongoing Clinical Trials Overview 25

TLP-Coated Shunt Catheter – Product Status 25

TLP-Coated Shunt Catheter – Product Description 25

Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 26

Hydrocephalus Shunt – Product Status 26

Hydrocephalus Shunt – Product Description 26

H-Cubed Inc. Pipeline Products & Ongoing Clinical Trials Overview 27

Ambulatory System For Hydrocephalus Shunt – Product Status 27

Ambulatory System For Hydrocephalus Shunt – Product Description 27

Integra LifeSciences Holdings Corp Pipeline Products & Ongoing Clinical Trials Overview 28

CSF Management Device – Product Status 28

CSF Management Device – Product Description 28

Hydrocephalic Shunt – Product Status 29

Hydrocephalic Shunt – Product Description 29

Ventricular Drainage Device – Product Status 29

Ventricular Drainage Device – Product Description 29

Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 30

CADENCE Balloon Shunt – Product Status 30

CADENCE Balloon Shunt – Product Description 30

Microbot Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 31

Self-Cleaning Shunt (SCS) Catheter – Product Status 31

Self-Cleaning Shunt (SCS) Catheter – Product Description 31

Microbot Medical Ltd – Ongoing Clinical Trials Overview 32

Self-Cleaning Shunt (SCS) Catheter – Early Feasibility Study (EFS) Evaluating the Efficacy of Self-Cleaning Shunt (SCS) Shunt Catheter 33

Monitor Med Solutions Pipeline Products & Ongoing Clinical Trials Overview 34

Hydrocephalus Shunt System – Product Status 34

Hydrocephalus Shunt System – Product Description 34

NeuraMedica, LLC Pipeline Products & Ongoing Clinical Trials Overview 35

Dural Clip – Product Status 35

Dural Clip – Product Description 35

Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 36

Programmable Hydrocephalus Stent – Product Status 36

Programmable Hydrocephalus Stent – Product Description 36

System Science Inc. Pipeline Products & Ongoing Clinical Trials Overview 37

Acute Cerebrospinal Fluid Monitor And Control System – Product Status 37

Acute Cerebrospinal Fluid Monitor And Control System – Product Description 37

Implantable Cerebrospinal Fluid Monitor And Control System – Product Status 38

Implantable Cerebrospinal Fluid Monitor And Control System – Product Description 38

University Hospital Zurich Pipeline Products & Ongoing Clinical Trials Overview 39

SmartShunt – Product Status 39

SmartShunt – Product Description 39

University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 40

Non – Obstructive Cerebral Shunt System – Product Status 40

Non – Obstructive Cerebral Shunt System – Product Description 40

University of Iowa Pipeline Products & Ongoing Clinical Trials Overview 41

Distal Catheter – Product Status 41

Distal Catheter – Product Description 41

University of Rochester Pipeline Products & Ongoing Clinical Trials Overview 42

Catheterless Shunt System – Product Status 42

Catheterless Shunt System – Product Description 42

University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 43

Shunt Catheter System With Inline Filter – Product Status 43

Shunt Catheter System With Inline Filter – Product Description 43

Sonic Window Cranioplasty Implant – Product Status 44

Sonic Window Cranioplasty Implant – Product Description 44

University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview 45

Gravity And Pressure Controlled Valve System – Product Status 45

Gravity And Pressure Controlled Valve System – Product Description 45

Hydrocephalus Stent – Product Status 46

Hydrocephalus Stent – Product Description 46

Smartvalve – Product Status 46

Smartvalve – Product Description 47

Vivonics Inc Pipeline Products & Ongoing Clinical Trials Overview 48

Shunt Flowmeter – Product Status 48

Shunt Flowmeter – Product Description 48

Wayne State University Pipeline Products & Ongoing Clinical Trials Overview 49

Programmable Antisiphon Shunt System – Product Status 49

Programmable Antisiphon Shunt System – Product Description 49

Glossary 65

Figures

Hydrocephalus shunts – Pipeline Products by Stage of Development 9

Hydrocephalus shunts – Pipeline Products by Segment 10

Hydrocephalus shunts – Pipeline Products by Territory 11

Hydrocephalus shunts – Pipeline Products by Regulatory Path 12

Hydrocephalus shunts – Pipeline Products by Estimated Approval Date 13

Hydrocephalus shunts – Ongoing Clinical Trials 14

Frequently asked questions

Hydrocephalus Shunts Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update standard reports
Currency USD
$2,500

Can be used by individual purchaser only

Most Popular
$5,000

Can be shared by unlimited users within one corporate location e.g. a regional office

$7,500

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Hydrocephalus Shunts Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Neurology Devices reports
Medical Devices
New
PTA Peripheral DCB Catheters Pipeline by Development Stages, Segments, Region…
$4,000 | March 2024
Medical Devices
New
PCR Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | March 2024
Medical Devices
New
Immunochemistry Analyzers Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | March 2024
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Hydrocephalus Shunts Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update in real time.

  • Access a live Hydrocephalus Shunts Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more